(S (NP (PRP We)) (VP (VBP propose) (NP (NP (DT a) (JJ new) (NN method)) (PP (IN for) (NP (NP (NN cancer) (NN subtype) (NN classification)) (PP (IN from) (NP (JJ histopathological) (NNS images))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD can) (ADVP (RB automatically)) (VP (VB detect) (NP (NP (JJ tumor-specific) (NNS features)) (PP (IN in) (NP (NP (DT a) (VBN given) (JJ whole) (NN slide) (NN image)) (PRN (-LRB- -LRB-) (NP (NNP WSI)) (-RRB- -RRB-))))))))))) (. .))
(S (NP (DT The) (NN cancer) (NN subtype)) (VP (MD should) (VP (VB be) (VP (VBN classified) (PP (IN by) (S (VP (VBG referring) (PP (TO to) (NP (NP (DT a) (NNP WSI)) (, ,) (NN i.e.) (, ,) (NP (NP (DT a) (JJ large-sized) (NN image)) (PRN (-LRB- -LRB-) (NP (ADVP (RB typically)) (CD 40,000x40,000) (NNS pixels)) (-RRB- -RRB-)) (PP (IN of) (NP (NP (DT an) (JJ entire) (JJ pathological) (NN tissue) (NN slide)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ consists) (PP (IN of) (NP (NN cancer) (CC and) (JJ non-cancer) (NNS portions))))))))))))))))) (. .))
(S (NP (CD One) (NN difficulty)) (VP (VBZ arises) (PP (IN from) (NP (NP (DT the) (JJ high) (NN cost)) (VP (VBN associated) (PP (IN with) (S (VP (VBG annotating) (NP (NP (NN tumor) (NNS regions)) (PP (IN in) (NP (NNP WSIs))))))))))) (. .))
(S (ADVP (RB Furthermore)) (, ,) (NP (ADJP (DT both) (JJ global) (CC and) (JJ local)) (NN image) (NNS features)) (VP (MD must) (VP (VB be) (VP (VBN extracted) (PP (IN from) (NP (DT the) (NNP WSI))) (PP (IN by) (S (VP (VBG changing) (NP (NP (DT the) (NNS magnifications)) (PP (IN of) (NP (DT the) (NN image)))))))))) (. .))
(S (PP (IN In) (NP (NN addition))) (, ,) (NP (DT the) (NN image) (NNS features)) (VP (MD should) (VP (VB be) (VP (ADVP (RB stably)) (VBN detected) (PP (IN against) (NP (NP (DT the) (NNS differences)) (PP (IN of) (NP (VBG staining) (NNS conditions))) (PP (IN among) (NP (DT the) (NNS hospitals/specimens)))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP develop) (NP (DT a) (JJ new) (JJ CNN-based) (NN cancer) (NN subtype) (NN classification) (NN method)) (PP (IN by) (S (VP (ADVP (RB effectively)) (VBG combining) (NP (UCP (NN multiple-instance) (, ,) (ADJP (NN domain) (JJ adversarial)) (, ,) (CC and) (ADJP (JJ multi-scale))) (NN learning) (NNS frameworks)) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB overcome) (NP (DT these) (JJ practical) (NNS difficulties)))))))))) (. .))
(S (SBAR (WHADVP (WRB When)) (S (NP (DT the) (VBN proposed) (NN method)) (VP (VBD was) (VP (VBN applied) (PP (TO to) (NP (NP (VB malignant) (NN lymphoma) (JJ subtype) (NNS classifications)) (PP (IN of) (NP (NP (CD 196) (NNS cases)) (VP (VBN collected) (PP (IN from) (NP (JJ multiple) (NNS hospitals)))))))))))) (, ,) (S (NP (DT the) (NN classification) (NN performance)) (VP (VBD was) (ADJP (ADJP (RB significantly) (JJR better)) (PP (IN than) (NP (NP (DT the) (JJ standard) (NNP CNN)) (CC or) (NP (JJ other) (JJ conventional) (NNS methods))))))) (, ,) (CC and) (S (NP (DT the) (NN accuracy)) (VP (VBN compared) (ADVP (RB favorably)) (PP (IN with) (NP (NP (DT that)) (PP (IN of) (NP (JJ standard) (NNS pathologists))))))) (. .))
